Brian Goff's holdings in Agios Pharmaceuticals are noteworthy. As of 2023, he has accumulated a significant number of vested stocks, amounting to a value of approximately $1.3 million. Over the past year, his stake has seen fluctuations as the company...
Brian Goff's holdings in Agios Pharmaceuticals are noteworthy. As of 2023, he has accumulated a significant number of vested stocks, amounting to a value of approximately $1.3 million. Over the past year, his stake has seen fluctuations as the company has gone through various milestones. The majority of his wealth is closely tied to performance-based stock units and options. Just a year ago, in 2022, he entered with considerable stock options, showing strong potential value if he successfully meets company goals. His financial interests are aligned with shareholder interests, making his investment in Agios highly relevant to his leadership role.